Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > REGULATORY
REGULATORY
- Olumiant, 7 More APIs Earn Orphan Designation: MHLW
March 12, 2021
- 2nd-Dose Shot Starts for COVID-19 Vaccination in Japan
March 12, 2021
- AMED to Fund 22 More Projects to Develop COVID-19 Treatments
March 11, 2021
- Govt Won’t Widely Recommend Use of 7-Dose Syringes for Pfizer Vaccine: Top Spokesman
March 10, 2021
- Medical Institutions Would Be Allowed to Provide 7 Doses per Vial of Pfizer’s COVID-19 Vaccine: Health Minister
March 10, 2021
- PMDA to Launch Working Group in April to Step Up Use of RWD
March 10, 2021
- Japan to Consider Ways to Speed Up Ivermectin Research for COVID-19
March 9, 2021
- Imfinzi, 2 Other Drugs under PMDA Safety Review
March 8, 2021
- Japan Speeds Up Vaccine Delivery for HCPs, Kono Says All 2nd Doses to Reach Municipalities in 1st Half of May
March 8, 2021
- MHLW Presents Views on “Pharma Industry Vision 2021” to LDP’s Project Team
March 8, 2021
- Japan Confirms 1st Case of Anaphylaxis from COVID-19 Vaccination
March 8, 2021
- Japan to Review Moderna Vaccine with Top Priority, May OK Possible: Minister
March 8, 2021
- Pfizer, Bayer to Pull Plug on “G1” Products with High Generic Erosions
March 5, 2021
- MHLW Announces New Drug Prices for 1st Off-Year Revision in April
March 5, 2021
- Vaccine Minister Says Govt to Stick to 3 Week Interval for Now
March 4, 2021
- MHLW Weighs 6-Week Dosing Interval for Pfizer Vaccine
March 4, 2021
- Vaccine Freezer Breakdown Due to Power Shortage: MHLW
March 4, 2021
- Nichi-Iko Ordered to Suspend Biz over Sloppy Manufacturing
March 3, 2021
- All Municipalities to Get 1 Carton of COVID-19 Vaccines for Elderly in Final Week of April: MHLW
March 3, 2021
- Freezers for Moderna Vaccine Could Be Used for Comirnaty Too: Campaign Minister
March 3, 2021
ページ
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s leading pharmaceutical wholesalers are bracing for a second consecutive year of profit declines, underscoring the growing challenge of generating…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…